Fulcrum Therapeutics Inc
NASDAQ:FULC
Cash Flow Statement
Cash Flow Statement
Fulcrum Therapeutics Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||
| Net Income |
(33)
|
(62)
|
(68)
|
(75)
|
(83)
|
(64)
|
(67)
|
(69)
|
(71)
|
(69)
|
(73)
|
(75)
|
(81)
|
(90)
|
(104)
|
(107)
|
(110)
|
(109)
|
(98)
|
(99)
|
(97)
|
(99)
|
(20)
|
(18)
|
(10)
|
(1)
|
(73)
|
(71)
|
|
| Depreciation & Amortization |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
3
|
4
|
4
|
5
|
6
|
7
|
7
|
8
|
8
|
9
|
11
|
13
|
13
|
14
|
13
|
14
|
14
|
15
|
15
|
14
|
15
|
16
|
15
|
14
|
12
|
12
|
|
| Other Non-Cash Items |
2
|
28
|
29
|
29
|
30
|
5
|
6
|
7
|
7
|
8
|
8
|
9
|
12
|
14
|
14
|
15
|
14
|
12
|
11
|
9
|
9
|
9
|
10
|
11
|
10
|
10
|
8
|
8
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
7
|
7
|
5
|
3
|
11
|
12
|
12
|
22
|
8
|
4
|
4
|
(13)
|
(12)
|
(11)
|
(6)
|
(9)
|
(3)
|
(5)
|
(7)
|
(0)
|
(5)
|
(3)
|
(4)
|
(3)
|
(4)
|
(3)
|
(1)
|
1
|
|
| Cash from Operating Activities |
(23)
N/A
|
(26)
-14%
|
(32)
-26%
|
(41)
-27%
|
(39)
+5%
|
(45)
-13%
|
(47)
-5%
|
(38)
+18%
|
(54)
-40%
|
(55)
-2%
|
(58)
-7%
|
(76)
-31%
|
(78)
-3%
|
(84)
-7%
|
(94)
-11%
|
(99)
-6%
|
(97)
+2%
|
(99)
-2%
|
(92)
+7%
|
(88)
+5%
|
(91)
-4%
|
(92)
-1%
|
(12)
+86%
|
(9)
+31%
|
(2)
+74%
|
8
N/A
|
(65)
N/A
|
(60)
+8%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||
| Capital Expenditures |
(9)
|
(9)
|
(5)
|
(4)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(56)
|
(56)
|
(42)
|
(56)
|
13
|
(13)
|
(134)
|
(128)
|
(121)
|
(62)
|
42
|
14
|
(99)
|
(112)
|
(91)
|
(36)
|
96
|
63
|
48
|
33
|
(6)
|
20
|
34
|
|
| Cash from Investing Activities |
(9)
N/A
|
(9)
+4%
|
(5)
+42%
|
(4)
+14%
|
(1)
+78%
|
(57)
-5 957%
|
(57)
0%
|
(43)
+25%
|
(57)
-34%
|
12
N/A
|
(14)
N/A
|
(135)
-836%
|
(130)
+4%
|
(122)
+6%
|
(65)
+47%
|
40
N/A
|
12
-69%
|
(101)
N/A
|
(113)
-11%
|
(91)
+19%
|
(37)
+60%
|
95
N/A
|
63
-34%
|
48
-23%
|
32
-33%
|
(7)
N/A
|
20
N/A
|
34
+72%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
105
|
92
|
80
|
80
|
0
|
1
|
65
|
65
|
71
|
119
|
54
|
192
|
187
|
139
|
142
|
85
|
84
|
202
|
199
|
118
|
118
|
2
|
2
|
3
|
3
|
1
|
1
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
80
|
79
|
64
|
64
|
0
|
65
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
105
N/A
|
92
-12%
|
79
-14%
|
65
-18%
|
64
0%
|
65
+0%
|
130
+101%
|
65
-50%
|
71
+10%
|
118
+66%
|
54
-54%
|
192
+256%
|
187
-3%
|
139
-25%
|
142
+2%
|
85
-40%
|
84
-1%
|
202
+139%
|
199
-1%
|
118
-41%
|
118
+0%
|
2
-98%
|
2
+11%
|
3
+27%
|
3
-7%
|
1
-60%
|
1
-7%
|
0
-56%
|
|
| Change in Cash | |||||||||||||||||||||||||||||
| Net Change in Cash |
73
N/A
|
58
-21%
|
42
-28%
|
19
-55%
|
24
+27%
|
(37)
N/A
|
26
N/A
|
(16)
N/A
|
(40)
-142%
|
75
N/A
|
(19)
N/A
|
(20)
-4%
|
(22)
-10%
|
(67)
-212%
|
(17)
+75%
|
25
N/A
|
(0)
N/A
|
1
N/A
|
(6)
N/A
|
(61)
-884%
|
(10)
+84%
|
5
N/A
|
53
+892%
|
43
-19%
|
33
-23%
|
2
-93%
|
(44)
N/A
|
(26)
+42%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||
| Free Cash Flow |
(32)
N/A
|
(34)
-9%
|
(37)
-9%
|
(46)
-22%
|
(40)
+12%
|
(46)
-14%
|
(48)
-4%
|
(39)
+18%
|
(55)
-40%
|
(56)
-1%
|
(60)
-7%
|
(78)
-31%
|
(80)
-3%
|
(86)
-7%
|
(96)
-12%
|
(102)
-5%
|
(99)
+3%
|
(101)
-2%
|
(93)
+8%
|
(88)
+6%
|
(91)
-4%
|
(92)
-1%
|
(13)
+86%
|
(9)
+31%
|
(2)
+71%
|
8
N/A
|
(65)
N/A
|
(60)
+7%
|
|